Moath Ahmad Albliwi , Internal Medicine Resident at Cleveland Clinic, shared an article he and his colleagues authored on X:
”Thrilled to share my first-author publication in CLML!
Comparative Outcomes of Intensive Chemotherapy vs Venetoclax + HMA in AML patients aged 60–75: A Propensity Score–Adjusted Cohort Study.”
Title: Comparative Outcomes of Intensive Chemotherapy Versus Venetoclax Plus Hypomethylating Agents in Acute Myeloid Leukemia Patients Aged 60 to 75 Years: A Propensity Score–Adjusted Cohort Study
Authors: Moath Albliwi, Emily C. Zabor, John Hanna, Jessica El-Asmar, Daniel P. Nurse, Ameed Bawwab, Hasan Abuamsha, Yomna Abu-Farsakh, Asad Rauf, Heya Batah, Ahmed Mohamed, Muaz Alsabbagh Alchirazi, Akriti G. Jain, John C Molina, Sophia Balderman, Abhay Singh, Aaron T. Gerds, Sudipto Mukherjee, Ronald M. Sobecks, Betty Hamilton, Anjali S. Advani, Hetty E. Carraway, Moaath K. Mustafa Ali
Read the Full Article.
More posts featuring AML on OncoDaily.